HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KIOM-79 prevents xylose-induced lens opacity and inhibits TGF-beta2 in human lens epithelial cells cultured under high glucose.

AbstractAIM OF THE STUDY:
To investigate the effects of KIOM-79 in preventing the development of diabetic complications, such as cataracts.
MATERIALS AND METHODS:
The inhibitory effects of KIOM-79 were assessed in a model of xylose-induced lens opacity and on changes mediated by high levels of glucose in human lens epithelial (HLE-B3) cells.
RESULTS:
In lenses treated with KIOM-79, opacity was significantly improved and glutathione (GSH) was increased compared to controls. In HLE-B3 cells treated with KIOM-79, high glucose-mediated increases in TGF-beta2, alphaB-crystallin, and fibronectin were significantly inhibited in a dose-dependent manner. KIOM-79 decreased the phosphorylation of p-Smad2/3, pp38MAPK, pp44/42, and NF-kappaB signaling in cells grown under high glucose conditions.
CONCLUSION:
KIOM-79 is protective against lens opacity and protects HLE-B3 cells from the toxic effects of high glucose. Therefore, KIOM-79 may provide a potential therapeutic approach for preventing diabetic complications, such as cataracts.
AuthorsNan Hee Kim, Young Sook Kim, Dong Ho Jung, Jin Sook Kim
JournalJournal of ethnopharmacology (J Ethnopharmacol) Vol. 130 Issue 3 Pg. 599-606 (Aug 09 2010) ISSN: 1872-7573 [Electronic] Ireland
PMID20561927 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCrown Copyright 2010. Published by Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • KIOM 79
  • Plant Extracts
  • Protective Agents
  • Transforming Growth Factor beta2
  • Xylose
  • Glutathione
  • Glucose
Topics
  • Cell Line
  • Corneal Opacity (prevention & control)
  • Dose-Response Relationship, Drug
  • Epithelial Cells (drug effects, metabolism)
  • Glucose (metabolism)
  • Glutathione (drug effects, metabolism)
  • Humans
  • Lens, Crystalline (cytology, drug effects)
  • Plant Extracts (administration & dosage, pharmacology)
  • Protective Agents (administration & dosage, pharmacology)
  • Signal Transduction (drug effects)
  • Transforming Growth Factor beta2 (antagonists & inhibitors)
  • Xylose (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: